Arecor Therapeutics plc (AIM:AREC)
London
· Delayed Price · Currency is GBP · Price in GBX 43.50
-0.73 (-1.69%)
Jun 6, 2025, 4:35 PM GMT+1
Arecor Therapeutics Market Cap
Arecor Therapeutics has a market cap or net worth of 16.42 million as of June 6, 2025. Its market cap has decreased by -66.17% in one year.
Market Cap
16.42M
Enterprise Value
13.40M
Revenue
5.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
43.50
Market Cap Chart
Since June 3, 2021, Arecor Therapeutics's market cap has decreased from 66.99M to 16.42M, a decrease of -75.48%. That is a compound annual growth rate of -29.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 16.42M | -40.82% |
| Dec 31, 2024 | 27.75M | -50.35% |
| Dec 29, 2023 | 55.89M | -23.94% |
| Dec 30, 2022 | 73.48M | -34.00% |
| Dec 31, 2021 | 111.34M | 66.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 166.94B |
| GSK plc | 61.28B |
| Haleon | 35.91B |
| Smith & Nephew | 9.47B |
| ConvaTec Group | 6.03B |
| Hikma Pharmaceuticals | 4.63B |
| HUTCHMED (China) | 1.91B |
| Genus | 1.30B |